Why is Global Health Ltd ?
1
High Management Efficiency with a high ROE of 15.69%
2
The company is Net-Debt Free
3
Poor long term growth as Operating profit has grown by an annual rate 15.40% of over the last 5 years
4
Negative results in Mar 26
- OPERATING PROFIT TO INTEREST (Q) Lowest at 9.13 times
- INTEREST(Q) Highest at Rs 26.71 cr
- PBT LESS OI(Q) At Rs 150.54 cr has Fallen at -6.9% (vs previous 4Q average)
5
With ROE of 15.8, it has a Expensive valuation with a 9.5 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 12.60%, its profits have risen by 10.3% ; the PEG ratio of the company is 6
6
High Institutional Holdings at 24.91%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Market Beating performance in long term as well as near term
- Along with generating 12.60% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Global Health should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Global Health for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Global Health
12.6%
0.43
29.02%
Sensex
-6.96%
-0.53
13.24%
Quality key factors
Factor
Value
Sales Growth (5y)
17.80%
EBIT Growth (5y)
15.40%
EBIT to Interest (avg)
8.47
Debt to EBITDA (avg)
1.10
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.51%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.91%
ROCE (avg)
22.40%
ROE (avg)
15.69%
Valuation Key Factors 
Factor
Value
P/E Ratio
61
Industry P/E
62
Price to Book Value
9.46
EV to EBIT
48.58
EV to EBITDA
37.06
EV to Capital Employed
10.13
EV to Sales
7.89
PEG Ratio
6.01
Dividend Yield
0.04%
ROCE (Latest)
21.78%
ROE (Latest)
15.83%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
5What is working for the Company
NET SALES(Latest six months)
At Rs 2,280.14 cr has Grown at 21.63%
-11What is not working for the Company
OPERATING PROFIT TO INTEREST (Q)
Lowest at 9.13 times
INTEREST(Q)
Highest at Rs 26.71 cr
PBT LESS OI(Q)
At Rs 150.54 cr has Fallen at -6.9% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Global Health
Net Sales - Quarterly
Highest at Rs 1,159.05 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Global Health
Operating Profit to Interest - Quarterly
Lowest at 9.13 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest - Quarterly
Highest at Rs 26.71 cr
in the last five quarters and Increased by 24.17 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 150.54 cr has Fallen at -6.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 161.71 CrMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 36.74 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






